Back

Drp1-JNK knockdown mitigates Scribble loss induced cell proliferation, metastasis and lethality phenotypes in Drosophila

Singh, J.; Srikrishna, S.

2024-04-13 cancer biology
10.1101/2024.04.10.588977 bioRxiv
Show abstract

Mitochondrial dynamics are emerging as master regulators for targeting several types of cancers, including breast cancer, cervical cancer, and hepatocellular carcinoma, for therapeutic intervention. Mitochondrial morphology, size, position and activity within cells is regulated by dynamic fission and fusion events. Dynamin-related protein 1 (Drp1) promotes mitochondrial fission and maintains mitochondrial homeostasis. Loss of Scrib is implicated in several human cancers wherein mitochondrial dysfunction leads to excessive cell proliferation and metastasis. However, the exact molecular mechanisms behind the Scrib loss induced dysregulation of mitochondrial dynamics in cancer progression remains obscure. Although the role of mitochondrial dynamics are being investigated in several types of cancers, but the role of Drp1- mediated fission event in regulating the maintenance of polarity of cells upon loss of Scrib function is elusive. In this study, for the first time, we blocked the function of Drp1 activity in Scrib knockdown induced metastasis cancer model by two ways, firstly, through genetic ablation of Drp1, and secondly by using mdivi-1, a Drp1 specific inhibitor. Genetic depletion of Drp1 expression (Drp1RNAi) in Scrib knockdown cells inhibits Metalloproteinase MMP1, reduces ROS production, restores apico-basal (A/B) cell polarity and enhances ATP production. Further to confirm role of Drp1 in regulation of cell polarity, we employed mdivi, a Drp1 specific inhibitor which has dose dependent effect in cell polarity regulation. This study also reveals that JNK inhibition (JNKRNAi) in Scrib abrogated cells mitigates the Drp1 expression and controls cell proliferation leading to restoration of mitochondrial morphology and epithelial cellpolarity. Our results highlight Drp1 as a key regulator in maintaining the apico-basal polarity of cells which gets affected upon loss of Scrib but Drp1-JNK downregulation effectively mitigates ScribRNAi associated cell proliferation, metastasis and pupal lethality phenotypes.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Cell Death Discovery
51 papers in training set
Top 0.1%
14.2%
2
PLOS ONE
4510 papers in training set
Top 19%
10.0%
3
Scientific Reports
3102 papers in training set
Top 20%
6.2%
4
Frontiers in Ecology and Evolution
60 papers in training set
Top 0.4%
4.8%
5
PLOS Genetics
756 papers in training set
Top 3%
4.8%
6
Cell Communication and Signaling
35 papers in training set
Top 0.2%
3.0%
7
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 2%
2.8%
8
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
28 papers in training set
Top 0.1%
2.3%
9
Biochemistry and Biophysics Reports
28 papers in training set
Top 0.3%
2.1%
50% of probability mass above
10
Cell Death & Disease
126 papers in training set
Top 0.7%
2.1%
11
Cancers
200 papers in training set
Top 3%
1.9%
12
Heliyon
146 papers in training set
Top 1%
1.9%
13
iScience
1063 papers in training set
Top 12%
1.9%
14
Experimental Cell Research
24 papers in training set
Top 0.1%
1.8%
15
Frontiers in Pharmacology
100 papers in training set
Top 2%
1.7%
16
Oncogene
76 papers in training set
Top 1%
1.7%
17
Journal of Cellular Biochemistry
10 papers in training set
Top 0.1%
1.7%
18
Translational Oncology
18 papers in training set
Top 0.2%
1.5%
19
Cells
232 papers in training set
Top 3%
1.3%
20
International Journal of Molecular Sciences
453 papers in training set
Top 10%
1.3%
21
Life Sciences
25 papers in training set
Top 0.9%
1.2%
22
Frontiers in Oncology
95 papers in training set
Top 3%
1.2%
23
PeerJ
261 papers in training set
Top 12%
0.9%
24
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.9%
25
Aging
69 papers in training set
Top 2%
0.9%
26
Biomolecules
95 papers in training set
Top 2%
0.9%
27
Cell Cycle
14 papers in training set
Top 0.3%
0.8%
28
Genes
126 papers in training set
Top 3%
0.7%
29
Oncotarget
15 papers in training set
Top 0.5%
0.7%
30
BMC Molecular and Cell Biology
14 papers in training set
Top 0.2%
0.7%